Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Healthpoint
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provide informed consent.
Age ≥ 18 years and of either sex.
Type I, II, or III skin as assessed by the Fitzpatrick Scale.
Willing to comply with protocol instructions, including allowing all study assessments.
Scheduled to have head or neck non-melanoma skin cancers removed by Mohs micrographic surgery with final wound size of 8 mm to 20 mm in diameter or with 8 mm to 20 mm long axis if not circular.
Acceptable state of health and nutrition, in the opinion of the Investigator.
You may not be if
History of anaphylaxis, serum sickness, or erythema multiforme reaction to aprotinin, bovine serum albumin or bovine serum proteins, penicillin, streptomycin, or amphotericin B.
Therapy with blood-thinning agents including aspirin within 14 days of the Baseline Visit (these may be resumed post-surgery).
Subjects with platelet or coagulation disorders.
Therapy with another investigational agent within thirty (30) days of Screening, or during the study.
Current systemic therapy with cytotoxic drugs.
Current therapy with chronic (\> 10 days) oral corticosteroids.
In the opinion of the Investigator the subject has a current life expectancy of less than 1 year.
Clareo Health | Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients
